ELEM Biotech
ELEM Biotech creates populations of virtual humans to predict clinical and device outcomes and support decision-making in drug and medical-device development. They run supercomputer-based patient…
ELEM Biotech
ELEM Biotech creates populations of virtual humans to predict clinical and device outcomes and support decision-making in drug and medical-device development. They run supercomputer-based patient…
TL;DR
What they do: Physics-based 'Virtual Humans' platform (Alya Red / V.HEART) for in silico clinical trials and device simulation
Headquarters: Barcelona, Spain
Founded: 2018
Customers: Pharmaceutical companies, MedTech companies, and CROs
Recent funding stage: Pre-Seed (Dec 19, 2022)
Company Overview
Problem Domain
Reducing reliance on physical trials by simulating clinical/device outcomes for drug and medical-device development and regulatory/commercial evidence generation.
Founded
2018
Industry
Biotechnology
Tech Stack
Funding Track Record
Most recent recorded round
Investor Signal
“European Innovation Council”
Founders
What we do
Join the Team
The Quality Assurance & Regulatory Officer (QARO) plays a hands-on role within ELEM’s Quality and Regulatory Affairs.
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |